NanoViricides issues warrants exercisable at US$1.75 in US$3.8 million registered direct offering
NNVC•Expected proceeds and closing
Gross proceeds are expected to be about US$3.8 million. Closing is targeted around July 27, 2026.
Registered direct offering terms
NanoViricides priced a registered direct offering with warrants covering 2,516,339 common shares, matching the common stock sold.
Each warrant is exercisable at US$1.75 per share and expires 5.5 years from issuance.
